Primary Research · 2005
Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy: a long-term, randomised, double-blind, placebo-controlled study
Sima AA, Calvani M, Mehra M, Amato A · Diabetes Care, 2005
Key finding
52-week RCT (n=1,257) found ALCAR 1000mg three times daily improved vibration perception, sural nerve fiber regeneration, and pain scores in diabetic peripheral neuropathy.
About the supplement
Acetyl-L-Carnitine (ALCAR)
Dose · mechanism · evidence grade · safety →
Read the paper
Open on PubMedhttps://pubmed.ncbi.nlm.nih.gov/15616229/
About this page
Formulate maintains a registry of clinical studies cited across its guides and evidence grades. This page links the study metadata to the content that cites it — one canonical entry per landmark study.
The full citation chain is public so readers can verify claims without hunting through individual guide pages. Browse all cited studies →
Note: Study summaries on this page are editorial interpretations of the research. Always consult the primary source before drawing clinical conclusions.